Make Your Xarelto LawsuitA Reality

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical companies, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to complete kavigames.com so could be grounds for compensation. Our lawyers are operating tough to have these hurt by the drug the compensation they may be entitled to.

Whilst bleeding is really a frequent complication related with anticoagulants, it has been alleged that Xarelto is a lot more harmful than conventional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, in the event of an emergency, individuals could be at danger for irreversible bleeding issues, which includes life-threatening internal and gastrointestinal hemorrhaging.

In the event you or a loved one particular suffered a critical bleeding occasion soon after taking Xarelto, you may have legal recourse. For more data, make contact with us today to have your case reviewed, free of charge of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in situations of death, funeral costs. Additionally, they are looking for punitive damages, that are generally awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.

Visit this page for much more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.